Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 13701 - 13725 of 14777 in total
Investigational
GVAX is a granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transfected tumor cell vaccine.
Investigational
Investigational
Investigational
CNDO-109 are CNDO-109-activated allogeneic natural killer cells.
Investigational
G305 is a recombinant NY-ESO-1 protein plus glucopyranosyl lipid A (GLA) in a stable emulsion (SE). G305 is an active component of CMB305 along with LV305.
Investigational
Matched Description: … G305 is an active component of CMB305 along with [LV305].[L47346] …
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Maveropepimut-S is a T cell activating immunotherapy.
Investigational
ICG-136 is a compound chimeric antigen receptor (cCAR) T-cell therapy developed by iCell Gene Therapeutics. It was investigated for the treatment of acute myeloid leukemia.
Investigational
Matched Description: … It was investigated for the treatment of acute myeloid leukemia. …
Investigational
Investigational
Investigational
Investigational
Obecabtagene autoleucel is an investigational autologous CD19 CAR T cell therapy.
Investigational
AMG-119 are CAR-T cells targeting delta-like ligand 3 (DLL3).
Investigational
Gavocabtagene autoleucel is a novel cell therapy consisting of autologous genetically engineered T cells expressing a single-domain antibody that recognizes human Mesothelin, fused to the CD3-epsilon subunit which, upon expression, is incorporated into the endogenous T cell receptor (TCR) complex.
Investigational
Matched Description: … Gavocabtagene autoleucel is a novel cell therapy consisting of autologous genetically engineered T cells …
Displaying drugs 13701 - 13725 of 14777 in total